Literature DB >> 20964983

The accelerated drug approval.

Gary D Novack.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20964983     DOI: 10.1016/s1542-0124(12)70235-5

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


× No keyword cloud information.
  2 in total

1.  Expedited regulatory product approval in the time of COVID-19.

Authors:  Gary D Novack
Journal:  Ocul Surf       Date:  2022-05-28       Impact factor: 6.268

2.  FDA review times for new drugs in ophthalmology.

Authors:  Michelle A Carpenter; Gary D Novack
Journal:  Ocul Surf       Date:  2020-08-11       Impact factor: 5.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.